Anxiolytic Drugs for Anxiety: Adverse Effects May Be Worse Than the Mood Disorder. A Case of Buspirone Induced Facial Dyskinesia

Dopamine, a neurotransmitter for motor function, is implicated in dyskinetic illness. Movement disorders are significant adverse drug effects (ADEs) of several psychotropic drugs with anti-dopamine action. Buspirone, an azapirone, is a partial agonist to serotonin 5HT1A. The medication's therapeutic advantages relate to its interaction with these receptors. Buspirone also inhibits dopamine receptors, which could be linked to the medication's unusual side effects in individuals who are predisposed to them.